Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study
- 1 March 1999
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (3), 832
- https://doi.org/10.1200/jco.1999.17.3.832
Abstract
F1000Prime Recommended Article: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.Keywords
This publication has 56 references indexed in Scilit:
- Effects of Medulloblastoma Resections on Outcome in Children: A Report from the Children's Cancer GroupNeurosurgery, 1996
- Prognostic Factors in Children with Supratentorial (Nonpineal) Primitive Neuroectodermal TumorsPediatric Neurosurgery, 1995
- Pattern of recurrence of medulloblastoma after low-doseInternational Journal of Radiation Oncology*Biology*Physics, 1994
- The Surgical and Natural Morbidity of Aggressive Resection for Posterior Fossa Tumors in ChildhoodPediatric Neurosurgery, 1994
- Neuraxis dissemination in pediatric brain tumors. Response to preirradiation chemotherapyCancer, 1992
- Current Neurosurgical Treatment of Medulloblastomas in ChildrenPediatric Neurosurgery, 1989
- Long-term endocrine sequelae after surgery, radiotherapy, and chemotherapy in children with medulloblastomaCancer, 1987
- Medulloblastoma in childhood: results of radical resection and low-dose neuraxis radiation therapyJournal of Neurosurgery, 1986
- Radiotherapy for primary brain tumors in very young childrenCancer, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958